Upcoming System Maintenance

Notice:Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.
Phone: (608) 274-4330
Toll-Free Phone: (800) 356-9526
Email: custserv@promega.com
Hours: 7am – 6pm, CST, Monday-Friday

Maxwell® 16 IVD Instrument Operating Manual

Instructions for Use of Product(s)

Literature # TM315

This product is only available in certain European countries and Canada.

The Maxwell® 16 IVD Instrument is intended for use as an IVD accessory, when used in the IVD mode with the Maxwell® 16 Blood DNA Purification System (Cat.# AS1015) or the Maxwell® 16 Viral Total Nucleic Acid Purification System (Cat.# AS1155). The instrument is used in combination with the Maxwell® 16 Blood DNA Purification System (Cat.# AS1015) to perform automated isolation of genomic DNA from human whole blood or buffy coat samples. Samples collected in blood collection tubes treated with EDTA, heparin or citrate can be used. The instrument is used in combination with the Maxwell® 16 Viral Total Nucleic Acid Purification System (Cat.# AS1155) to perform automated isolation of viral total nucleic acid from human plasma or serum samples.

The nucleic acid isolated using the Maxwell® 16 IVD Instrument is suitable for direct downstream analysis by standard amplification methods. These methods include a variety of polymerase chain reaction (PCR) tests for human in vitro diagnostic purposes. The Maxwell® 16 IVD Instrument is not intended for use as part of a specific in vitro diagnostic test. The Maxwell® 16 IVD Instrument is intended for professional use only. Diagnostic results obtained using nucleic acid purified with this system must be interpreted in conjunction with other clinical or laboratory data. 

The Maxwell® 16 IVD Instrument is intended for use in the following countries only: Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Summary of Changes:

The following change were made to the 4/15 revision of this document:
Figure 7 was updated to correct labeling of the back and front of the Magnetic Rod Assembly.


Printed in USA Revised 4/15.

Complete Protocol
PDF (1761k)